Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, In Diabetic eNOS knockout mice

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1221-1229

  Kosugi, Tomoki ^a   Heinig, Marcelo ^a   Nakayama, Takahiro ^a   Connor, Thomas ^a   Yuzawa, Yukio ^a   Li, Qiuhong ^b   Hauswirth, William W ^b   Grant, Maria B ^a   Croker, Byron P ^c   Campbell Thompson, Martha ^c   Zhang, Li ^c   Atkinson, Mark A ^c   Segal, Mark S ^a   Nakagawa, Takahiko ^a,d  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HYDRALAZINE; INSULIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; ANTIHYPERTENSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CELL DAMAGE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MODEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; HYPERTENSION; KIDNEY INJURY; KIDNEY INTERSTITIUM; KNOCKOUT MOUSE; MALE; MESANGIOLYSIS; MESANGIUM CELL; MICROANEURYSM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; MESANGIUM; MOUSE MUTANT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; HYDRALAZINE; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

EID: 65349142464     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080605     Document Type: Article

References (36)

1. Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T: Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 2007, 170:1473-1484
2. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell- Thompson M, Yuzawa Y, Atkinson M, Johnson RJ, Croker B: Diabetic eNOS knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007, 18:539-550
3. Parving HH, Hovind P, Rossing K, Andersen S: Evolving strategies for renoprotection: diabetic nephropathy. Curr Opin Nephrol Hypertens 2001, 10:515-522
4. Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL: Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 2001, 104:2391-2394
5. Nakagawa T, Lan HY, Glushakova O, Zhu HJ, Kang DH, Schreiner GF, Bottinger EP, Johnson RJ, Sautin YY: Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of throm- bospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. J Am Soc Nephrol 2005, 16:899-904
6. Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N, Matsuo S, Kadomatsu K: Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest 2007, 87:903-913
7. Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, Muramatsu T, Kadomatsu K: Growth factor midkine is involved in the pathogen- esis of diabetic nephropathy. Am J Pathol 2006, 168:9-19
8. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat-functional and structural characteristics. J Hypertens 1988, 6:1009-1016
9. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 1998, 54:343-352
10. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002, 346:913-923
11. Quiroz Y, Pons H, Gordon KL, Rincon J, Chavez M, Parra G, Herrera- Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ, Rodriguez- Iturbe B: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 2001, 281:F38-F47
12. Edwards RM, Trizna W: Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. J Am Soc Nephrol 1993, 4:1127-1132
13. Patzak A, Kleinmann F, Lai EY, Kupsch E, Skelweit A, Mrowka R: Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice. Acta Physiol Scand 2004, 181:439-444
14. Hohenstein B, Braun A, Amann KU, Johnson RJ, Hugo CP: A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Nephrol Dial Transplant 2008, 23: 1144-1156
15. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, KurokawaK, Couser WG, Johnson RJ: A new model of renal microvascular endo- thelial injury. Kidney Int 1997, 52:182-194
16. Heilig C, Zaloga C, Lee M, Zhao X, Riser B, Brosius F, Cortes P: Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Lab Invest 1995, 73:674-684
17. Han DC, Isono M, Hoffman BB, Ziyadeh FN: High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 1999, 10:1891-1899
18. Yang YL, Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Huang YL: Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin. Biochem J 2004, 379:89-97
19. Yung S, Lee CY, Zhang Q, Lau SK, Tsang RC, Chan TM: Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. Nephrol Dial Transplant 2006, 21:1504-1513
20. Wang S, Shiva S, Poczatek MH, Darley-Usmar V, Murphy-Ullrich JE: Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J Biol Chem 2002, 277:9880-9888
21. Hammerman MR: Interaction of insulin with the renal proximal tubular cell. Am J Physiol 1985, 249:F1-F11
22. Meier M, Nitschke M, Hocke C, Kramer J, Jabs W, Steinhoff J, Schutt M: Insulin inhibits caspase-3 activity in human renal tubular epithelial cells via the PI3-kinase/Akt pathway. Cell Physiol Biochem 2008,21:279-286
23. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996, 45:522-530
24. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitrans- forming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000, 97:8015-8020
25. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE: The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999, 274:13586-13593
26. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE: Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 1995, 270:7304-7310
27. Daniel C, Schaub K, Amann K, Lawler J, Hugo C: Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes 2007, 56:2982-2989
28. Iwazu Y, Muto S, Fujisawa G, Nakazawa E, Okada K, Ishibashi S, Kusano E: Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis. Hypertension 2008, 51:749-754
29. Advani A, Kelly DJ, Advani SL, Cox AJ, Thai K, Zhang Y, White KE, Gow RM, Marshall SM, Steer BM, Marsden PA, Rakoczy PE, Gilbert RE: Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci USA 2007, 104:14448-14453
30. Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, O'Young G, Sannajust F, Stathis P, Schreiner G, Karumanchi SA, Protter AA, Pollitt NS: Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007, 50:686-692
31. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001, 12:993-1000
32. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002, 51:3090-3094
33. Kanesaki Y, Suzuki D, Uehara G, Toyoda M, Katoh T, Sakai H, Watanabe T: Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic ne- phropathy. Am J Kidney Dis 2005, 45:288-294
34. Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR: Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int 2005, 67:167-177
35. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001, 37:601-611
36. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: i. Potential role of vascular endothelial growth factor and throm- bospondin-1, J Am Soc Nephrol 2001, 12:1434-1447